Precision Oncology in Clinical Cancer Genomics

Dear Colleagues,

Precision medicine can be defined as the tailoring of medicine to suit a group of people or a specific individual, based on genetic or molecular profiling using genomic, transcriptomic, epigenomic, or proteomic information. When applied to cancer, personalized medicine is known as precision oncology and promises to revolutionise cancer management by optimising patient treatment, personalised screening, diagnosis, therapy, and monitoring. This can only be accomplished using large data sets which need to be processed, integrated, and analysed to identify molecular patterns. Precision oncology can result in treatments with less side effects and ensure higher patient survival rates, through increased control and management. Population-group-specific diagnostic or prognostic biomarkers can be identified through the analysis of these molecular patterns that could also be used to track the progress of the disease and monitor the response to treatments and detect drug resistance. This surveillance may even allow for the identification and targeting of molecular pathways involved in drug resistance. I would like to invite submissions of original research or review articles on any topic related to “Precision Oncology in Clinical Cancer Genomics”. This collection will cover cancer clinical decision making and care. I look forward to receiving your contributions.

Prof. Dr. Zodwa Dlamini
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.